The WACC of Poseida Therapeutics, Inc. (PSTX) is 8.2%.
| Range | Selected | |
| Cost of equity | 6.90% - 9.60% | 8.25% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 12.70% | 9.85% |
| WACC | 6.8% - 9.6% | 8.2% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.66 | 0.85 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.90% | 9.60% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.06 | 0.06 |
| Cost of debt | 7.00% | 12.70% |
| After-tax WACC | 6.8% | 9.6% |
| Selected WACC | 8.2% | |